Cipher Pharmaceuticals Stock Analysis

Cipher Stock Analysis Notes

About 42.0% of the company shares are held by company insiders. The book value of Cipher Pharmaceuticals was currently reported as 3.86. The company had not issued any dividends in recent years. Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company was founded in 2000 and is headquartered in Oakville, Canada. CIPHER PHARMACEUTICALS operates under Drug Manufacturers - Specialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs people. For more info on Cipher Pharmaceuticals please contact the company at 905 602 5840 or go to https://www.cipherpharma.com.

Cipher Pharmaceuticals Investment Alerts

Cipher Largest EPS Surprises

View All Earnings Estimates

Cipher Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 364.39 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cipher Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Cipher Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Cipher Profitablity

The company has Profit Margin (PM) of 0.6 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.

Management Efficiency

Cipher Pharmaceuticals has return on total asset (ROA) of 0.0506 % which means that it generated a profit of $0.0506 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1798 %, meaning that it generated $0.1798 on every $100 dollars invested by stockholders. Cipher Pharmaceuticals' management efficiency ratios could be used to measure how well Cipher Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 27th of November 2024, Return On Tangible Assets is likely to grow to 0.31. Also, Return On Capital Employed is likely to grow to 0.15. At this time, Cipher Pharmaceuticals' Debt To Assets are very stable compared to the past year. As of the 27th of November 2024, Return On Assets is likely to grow to 0.25, while Total Assets are likely to drop about 46.4 M.

Technical Drivers

As of the 27th of November, Cipher Pharmaceuticals shows the Mean Deviation of 2.91, risk adjusted performance of (0.01), and Standard Deviation of 4.05. Cipher Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Cipher Pharmaceuticals Price Movement Analysis

Cipher Pharmaceuticals Outstanding Bonds

Cipher Pharmaceuticals Predictive Daily Indicators

Cipher Pharmaceuticals Forecast Models

Cipher Pharmaceuticals' time-series forecasting models are one of many Cipher Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cipher Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cipher Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cipher shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cipher Pharmaceuticals. By using and applying Cipher Stock analysis, traders can create a robust methodology for identifying Cipher entry and exit points for their positions.

Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.